Detalles de la búsqueda
1.
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection.
Gastroenterology
; 152(1): 164-175.e4, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27720838
2.
The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis.
Gastroenterology
; 147(2): 366-76.e6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24727022
3.
A phase 2B study of MK-7009 (vaniprevir) in patients with genotype 1 HCV infection who have failed previous pegylated interferon and ribavirin treatment.
J Hepatol
; 59(1): 11-7, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23439259
4.
Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
Pediatr Infect Dis J
; 25(10): 912-9, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17006287
5.
Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
Pediatr Infect Dis J
; 24(8): 665-9, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16094217
6.
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.
Lancet HIV
; 2(8): e319-27, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26423374
7.
Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
Southeast Asian J Trop Med Public Health
; 35(4): 949-53, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15916096
8.
Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.
Antiviral Res
; 99(3): 214-20, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23747481
9.
Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).
Hum Vaccin
; 2(5): 205-14, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17035730
10.
A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
Pediatrics
; 117(2): 265-72, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16452343
11.
Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
Southeast Asian J Trop Med Public Health
; 2004 Dec; 35(4): 949-53
Artículo
en Inglés
| IMSEAR | ID: sea-34236
Resultados
1 -
11
de 11
1
Próxima >
>>